Alliancebernstein L.P. Igm Biosciences, Inc. Transaction History

Alliancebernstein L.P.

  • $278 Billion
  • Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 41,230 shares of IGMS stock, worth $711,629. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,230
Previous 32,300 27.65%
Holding current value
$711,629
Previous $311,000 9.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$6.51 - $11.47 $58,134 - $102,427
8,930 Added 27.65%
41,230 $283,000
Q4 2023

Feb 14, 2024
SELL
$3.94 - $8.79 $12,056 - $26,897
-3,060 Reduced 8.65%
32,300 $268,000
Q3 2023

Nov 14, 2023
BUY
$6.66 - $10.64 $17,249 - $27,557
2,590 Added 7.9%
35,360 $295,000
Q2 2023

Aug 15, 2023
BUY
$8.86 - $14.0 $60,868 - $96,180
6,870 Added 26.53%
32,770 $302,000
Q4 2022

Feb 14, 2023
BUY
$15.45 - $26.02 $24,781 - $41,736
1,604 Added 6.6%
25,900 $440,000
Q3 2022

Nov 15, 2022
SELL
$15.42 - $27.01 $9,313 - $16,314
-604 Reduced 2.43%
24,296 $552,000
Q2 2022

Aug 15, 2022
BUY
$13.27 - $25.5 $131,373 - $252,450
9,900 Added 66.0%
24,900 $449,000
Q3 2021

Nov 10, 2021
SELL
$65.76 - $90.65 $32,880 - $45,325
-500 Reduced 3.23%
15,000 $986,000
Q2 2021

Jul 30, 2021
BUY
$57.98 - $96.6 $202,930 - $338,100
3,500 Added 29.17%
15,500 $1.29 Million
Q1 2021

May 06, 2021
SELL
$71.56 - $121.23 $71,560 - $121,230
-1,000 Reduced 7.69%
12,000 $920,000
Q4 2020

Feb 08, 2021
SELL
$47.41 - $115.03 $4,741 - $11,503
-100 Reduced 0.76%
13,000 $1.15 Million
Q3 2020

Nov 12, 2020
BUY
$43.0 - $84.01 $90,300 - $176,421
2,100 Added 19.09%
13,100 $967,000
Q2 2020

Aug 13, 2020
BUY
$51.3 - $75.21 $138,510 - $203,066
2,700 Added 32.53%
11,000 $803,000
Q1 2020

May 14, 2020
BUY
$31.51 - $73.75 $261,533 - $612,125
8,300 New
8,300 $466,000

Others Institutions Holding IGMS

# of Institutions
89
Shares Held
21.4M
Call Options Held
39.5K
Put Options Held
16.5K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email